***As of 28 December 2021, Novo Nordisk completed its acquisition of Dicerna Pharmaceuticals. This episode was recorded prior to the acquisition on 26 August 2021.***

In this episode of One Step Ahead, Douglas Fambrough, Ph.D., President and CEO at Dicerna Pharmaceuticals, talks us through “RNA interference,” an innovative technique that can target and silence certain disease-causing genes. From kidney-related disease to neurological disorders – and potentially even alcohol use disorder – he asserts that gene-based medicines have the potential to be a safe and effective approach to treating disease. According to Dr. Fambrough, we’re at the early stages of a “big bang” for gene-based medicine, and RNAi is just one of many disruptive technologies set to change the future of healthcare.

This episode was presented by Libby Potter.

***As of 28 December 2021, Novo Nordisk completed its acquisition of Dicerna Pharmaceuticals. This episode was recorded prior to the acquisition on 26 August 2021.***
In this episode of One Step Ahead,&nbsp;Douglas Fambrough,&nbsp;Ph.D., President and CEO at Dicerna Pharmaceuticals, talks us through &ldquo;RNA interference,&rdquo; an innovative technique that can target and silence certain disease-causing genes. From kidney-related disease to neurological disorders &ndash; and potentially even alcohol use disorder &ndash; he asserts that gene-based medicines have the potential to be a safe and effective approach to treating disease. According to Dr. Fambrough, we&rsquo;re at the early stages of a &ldquo;big bang&rdquo; for gene-based medicine, and RNAi is just one of many disruptive technologies set to change the future of healthcare.
This episode was presented by&nbsp;Libby Potter.

Technological innovation and the need to live more sustainably are profoundly reshaping how we travel, work and play. In this podcast, business leaders and industry disruptors break down how they’re adapting to these trends, preparing for what’s next, and helping to build a brighter future for our planet. Our goal is to help you future-proof your portfolios in this world of constant change.

One Step Ahead is brought to you by Amundi ETF, a European pioneer of Exchange Traded Funds. To learn more about how you can keep your investments ahead of change, visit www.amundietf.com 

This podcast is for informational purposes only, and should not be taken as investment advice and/or an offer to buy financial products.

Technological innovation and the need to live more sustainably are profoundly reshaping how we travel, work and play. In this podcast, business leaders and industry disruptors break down how they&rsquo;re adapting to these trends, preparing for what&rsquo;s next, and helping to build a brighter future for our planet. Our goal is to help you future-proof your portfolios in this world of constant change.
One Step Ahead is brought to you by Amundi ETF, a European pioneer of Exchange Traded Funds. To learn more about how you can keep your investments ahead of change, visit <a href="http://www.amundietf.com">www.amundietf.com</a>&nbsp;<a href="http://www.amundietf.co.uk"></a>
This podcast is for informational purposes only, and should not be taken as investment advice and/or an offer to buy financial products.

Advertisement